Steadfast commitment to UV1 progression

Flash note | Pharmaceuticals & healthcare | 18/04/2024

AbbVie deal clears antitrust hurdle

Flash note | Pharmaceuticals & healthcare | 18/04/2024

FY24 underpinned by market share gains

Flash note | Property | 18/04/2024

Decarbonisation fuelling growth

Outlook | General Industrials | 18/04/2024

Executing on a high-growth strategy

Update | Financials | 18/04/2024

An enhanced value creation strategy

Flash note | Consumer staples | 18/04/2024

When one plus one equals three

Update | Mining | 17/04/2024

Global growth generates record net profit

QuickView | Alternative Energy | 17/04/2024

Baked in AI opportunities

QuickView | Media | 17/04/2024

Multiple positives should excite investors

Flash note | General Industrials | 17/04/2024

Several potential portfolio catalysts on the horizon

Update | Technology | 16/04/2024

First patient dosed in Phase IIb XanaMIA study

Flash note | Pharmaceuticals & healthcare | 16/04/2024

CS014 (thrombosis) progresses towards the clinic

Flash note | Pharmaceuticals & healthcare | 16/04/2024

FY23 growth driven by idiosyncratic factors

Review | Investment trusts | 16/04/2024

Transformative FY23 with revenue rocketing

QuickView | Alternative Energy | 16/04/2024

FY23 focused on margin management

Update | Basic Industries | 16/04/2024

Growing the base

QuickView | Food & Drink | 16/04/2024

New product launch and contract wins

Flash note | Technology | 15/04/2024

All looking good in terms of income and growth

Update | Investment trusts | 15/04/2024

Delivering income and capital growth

Update | Investment trusts | 15/04/2024

Introducing redeemable shares

Update | Investment trusts | 12/04/2024

Funding accelerates Tedopi clinical development

Flash note | Pharmaceuticals & healthcare | 12/04/2024

Cutting the final link to PFS vendors

Update | Technology | 12/04/2024

Is the tide turning?

Review | Investment trusts | 12/04/2024

FY24 trading in line with expectations

Flash note | Construction & Building Materials | 12/04/2024

Harvesting the power of seaweed

QuickView | General Retailers | 11/04/2024

Moving into alignment

QuickView | Media | 11/04/2024

Several key holdings funded to break-even

Update | Investment trusts | 10/04/2024

Quality of UEM’s assets is underappreciated

Review | Investment trusts | 10/04/2024

CARB-X grant for preclinical programs

Flash note | Pharmaceuticals & healthcare | 10/04/2024

Serving the energy transition

Initiation | Industrial Support Services | 09/04/2024

Performing as expected ahead of refinancing

Flash note | Property | 09/04/2024

Deep dive on developers

Update | Investment trusts | 09/04/2024

Accretive portfolio repositioning

Flash note | Property | 09/04/2024

FDA green light for SCLC combination trial

Flash note | Pharmaceuticals & healthcare | 09/04/2024

Accelerating again in FY24

Update | Financials | 08/04/2024

Google strategic collaboration

Flash note | Technology | 08/04/2024

Beyond PD-LID, a closer look at PD-psychosis

Update | Pharmaceuticals & healthcare | 08/04/2024

Holding a strong hand

Initiation | Technology | 05/04/2024

Third time is a charm; INNOVATIVE SME Seal

Flash note | Pharmaceuticals & healthcare | 05/04/2024

Gross proceeds of c SEK69m to advance pipeline

Flash note | Pharmaceuticals & healthcare | 04/04/2024

Strong share price on supportive fundamentals

Update | Financials | 04/04/2024

Zevtera crosses key US regulatory hurdle

Update | Pharmaceuticals & healthcare | 04/04/2024

Amapá optimisation adds value

Update | Mining | 04/04/2024

Rising star

Initiation | Technology | 04/04/2024

Positive signals abound

Flash note | Pharmaceuticals & healthcare | 04/04/2024

A decisive period ahead for SDC-1801

Update | Pharmaceuticals & healthcare | 03/04/2024

Growing up

Update | Mining | 03/04/2024

Reaffirmed long-term focus on outpatient CAR-T

Update | Pharmaceuticals & healthcare | 03/04/2024

Positive steps towards ambitious FY24 goals

Flash note | Technology | 03/04/2024

Market tough through H124

Update | Consumer Support Services | 03/04/2024

Anticipating record adjusted PBT in FY24

QuickView | General Industrials | 02/04/2024

Showing us how it's done

Outlook | Food & Drink | 02/04/2024

A busy end to a record FY23

Update | Industrial Support Services | 02/04/2024

Pipeline momentum builds into FY24

Update | Pharmaceuticals & healthcare | 02/04/2024

FY23 results in line with market conditions

Flash note | Financials | 28/03/2024

The power of marginal gains

QuickView | Travel & Leisure | 28/03/2024

Regulatory green light for CADENCE trial

Flash note | Pharmaceuticals & healthcare | 28/03/2024

Full steam ahead

Update | Financials | 28/03/2024

A strong hand

QuickView | Travel & Leisure | 28/03/2024

Extension of recovery horizon

QuickView | Media | 28/03/2024

FY24 revenue growth of 5.8%

Flash note | Technology | 27/03/2024

Fizzing away

QuickView | Consumer staples | 27/03/2024

FY23 reserves show solid replacement rates

Flash note | Oil & gas | 27/03/2024

R&D advance (A$11.18m) extends runway

Update | Pharmaceuticals & healthcare | 26/03/2024

Marching towards US clinical trials for NXC-201

Flash note | Pharmaceuticals & healthcare | 26/03/2024

Strong FY23 results with strategic review in FY24

Flash note | Investment trusts | 25/03/2024

On the move

QuickView | Travel & Leisure | 25/03/2024

FDA thumbs up to mesdopetam’s Phase III plan

Flash note | Pharmaceuticals & healthcare | 25/03/2024

Growth in a tough market

Update | Technology | 25/03/2024

First transparency milestone achieved

Flash note | Technology | 25/03/2024

Funding the gap to commercial revenues

Update | General Industrials | 25/03/2024

Acquisitions generating more green

QuickView | Alternative Energy | 25/03/2024

Proposed merger with Henderson European Focus Trust

Flash note | Investment trusts | 22/03/2024

Strong earnings growth and realisations in FY23

Update | Investment trusts | 22/03/2024

Clarity and focus on key platforms

QuickView | Media | 22/03/2024

Termination of coverage

Update | Technology | 22/03/2024

Capitalising on renewable ambitions

QuickView | Alternative Energy | 22/03/2024

Termination of coverage

Update | Pharmaceuticals & healthcare | 22/03/2024

Termination of coverage

Update | Pharmaceuticals & healthcare | 22/03/2024

Termination of coverage

Update | Property | 22/03/2024

Termination of coverage

Update | Investment trusts | 22/03/2024

Termination of coverage

Update | Media | 22/03/2024

Record results for FY23

QuickView | Industrial Support Services | 22/03/2024

Financial and operational progress

Update | Property | 22/03/2024

Steady as she goes

Flash note | Consumer Support Services | 22/03/2024

Medium-term targets come into view

Update | Property | 21/03/2024

Motoring forward

Update | Industrial Support Services | 21/03/2024

Business as usual ahead of manager’s retirement

Update | Investment trusts | 21/03/2024

Positioned to benefit from re-emerging confidence

Update | Media | 21/03/2024

Diversification paying dividends

Update | Industrial Support Services | 20/03/2024

Making the complex simple for global merchants

Outlook | Technology | 20/03/2024

Strongest year since FY18

Update | Technology | 20/03/2024

Mesdopetam’s potential highlighted in PD-psychosis

Flash note | Pharmaceuticals & healthcare | 20/03/2024

Evenamide set for a pivotal year

Update | Pharmaceuticals & healthcare | 20/03/2024

Onwards and upwards for performance recovery

Update | Investment trusts | 20/03/2024

Growth and returns, acquisition bolsters outlook

Update | Technology | 19/03/2024

A good end to FY23

Update | Travel & Leisure | 19/03/2024

One step closer to key data readouts

Flash note | Pharmaceuticals & healthcare | 19/03/2024

Celebrating the Ides of March

Update | Mining | 18/03/2024